Grant: Discovery Grants Program - Individual
Simon Fraser University
$31,000.00
Development of automated single cell manipulation and analysis techniques for rare cell applications
EF 2015-16
Résumé
The proposed research program will develop novel manipulation and analysis techniques for rare single cells. Single cell analysis is an emerging field that is gaining significant interest in life/health sciences since it can facilitate accurate studies of cellular and molecular behaviours of living cells. This will further our knowledge about cell plasticity, heterogeneity, monitoring infections, auto-immunity, drug delivery, stem cell analysis, or cancer cell detection-all at the single cell level. These applications and other advances in life sciences and health research are driving the need to develop new techniques and tools that can rapidly perform more complex and accurate single cell analysis.
The immediate goal will be to isolate and characterize rare circulating tumor cells (CTCs) in the peripheral blood at single cell resolution. CTCs are neoplastic cells shed from primary tumors that are found in blood and are believed to seed secondary tumors (i.e. metastasis). Therefore, identifying and characterizing CTCs in blood has the prospect of providing a means of identifying patients who have developed metastatic disease and provide an early detection method. Furthermore, analysis of CTCs for specific cellular and molecular changes has the potential of identifying effective therapies as specific features of tumor cells determine the therapeutic strategy used. Thus, there is much interest in better methods to detect, isolate, and characterize CTCs from blood samples. The research program will first target the CTCs in metastatic prostate cancer. In Canada, an estimated 25,000 men will be diagnosed with the disease every year and 4,000 will die from it. Recent studies suggest CTC count to be a more powerful early predictor of survival than prostate-specific antigen (PSA).
The proposed research program will result in the creation of novel robotic-assisted techniques for automated single cell analysis that are tightly linked to and enabling of scientific discoveries in health research. This is a high-risk, high-benefit research that has potential for transformative technological advances in studying and diagnosing diseases and researching novel drug target identification.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
298219-2012
Name nom
Park, Edward
Department département
Mechatronic Systems Engineering
Organization id
5
Institution établissement
Simon Fraser University
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2012
Award amount
31000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1512
Committee name en
Mechanical Engineering
Committee name fr
Génie mécanique
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Partie
4
Nb partie
5
Application title
Development of automated single cell manipulation and analysis techniques for rare cell applications
Keyword
NSERC
Application summary
The proposed research program will develop novel manipulation and analysis techniques for rare single cells. Single cell analysis is an emerging field that is gaining significant interest in life/health sciences since it can facilitate accurate studies of cellular and molecular behaviours of living cells. This will further our knowledge about cell plasticity, heterogeneity, monitoring infections, auto-immunity, drug delivery, stem cell analysis, or cancer cell detection-all at the single cell level. These applications and other advances in life sciences and health research are driving the need to develop new techniques and tools that can rapidly perform more complex and accurate single cell analysis.
The immediate goal will be to isolate and characterize rare circulating tumor cells (CTCs) in the peripheral blood at single cell resolution. CTCs are neoplastic cells shed from primary tumors that are found in blood and are believed to seed secondary tumors (i.e. metastasis). Therefore, identifying and characterizing CTCs in blood has the prospect of providing a means of identifying patients who have developed metastatic disease and provide an early detection method. Furthermore, analysis of CTCs for specific cellular and molecular changes has the potential of identifying effective therapies as specific features of tumor cells determine the therapeutic strategy used. Thus, there is much interest in better methods to detect, isolate, and characterize CTCs from blood samples. The research program will first target the CTCs in metastatic prostate cancer. In Canada, an estimated 25,000 men will be diagnosed with the disease every year and 4,000 will die from it. Recent studies suggest CTC count to be a more powerful early predictor of survival than prostate-specific antigen (PSA).
The proposed research program will result in the creation of novel robotic-assisted techniques for automated single cell analysis that are tightly linked to and enabling of scientific discoveries in health research. This is a high-risk, high-benefit research that has potential for transformative technological advances in studying and diagnosing diseases and researching novel drug target identification.